CoChat

Traffic jam hypothesis: Relationship between endocytic dysfunction and Alzheimer's disease

Kimura, Nobuyuki, Yanagisawa, Katsuhiko · 2018 · Neurochemistry International
Cited by 36

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Membrane trafficking pathways, like the endocytic pathway, carry out fundamental cellular processes that are essential for normal functioning. One such process is regulation of cell surface receptor signaling. A growing body of evidence suggests that &bgr;‐amyloid protein (A&bgr;) plays a key role in Alzheimer's disease (AD) pathogenesis. Cleavage of A&bgr; from its precursor, &bgr;‐amyloid precursor protein (APP), occurs through the endocytic pathway in neuronal cells. In early‐stage AD, intraneuronal accumulation of abnormally enlarged endosomes is common, indicating that endosome trafficking is disrupted. Strikingly, genome‐wide association studies reveal that several endocytosis‐related genes are associated with AD onset. Also, recent studies demonstrate that alteration in endocytosis induces not only A&bgr; pathology but also the propagation of tau protein pathology, another key pathological feature of AD. Endocytic dysfunction can disrupt neuronal physiological functions, such as synaptic vesicle transport and neurotransmitter release. Thus, “traffic jams” in the endocytic pathway may be involved in AD pathogenesis and may serve as a novel target for the development of new therapeutics. Graphical abstract Age‐Related Endocytic Dysfunction is Involved in Alzheimer's Disease Pathology. Figure. No caption available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2017.07.002

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 36

Metadata

Authors
Kimura, N., & Yanagisawa, K.
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2018-10
Volume
119
Pages
35-41
ISSN
0197-0186 (ISSN-L)
OpenAlex
W2733602404
Cited by
36
References
20
FWCI
1.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.